tivoxavir marboxil
·Code: AV5124, TXM
tivoxavir marboxil: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| TRAWS PHARMA, INC. (ONTX) | Phase 2 |
FDA Decisions
FDA_MeetingThe Company received guidance from the FDA regarding its investigational bird flu and seasonal flu product candidate and plans for stockpiling for pandemic preparedness.(ONTX)
Frequently asked questions
Who is developing tivoxavir marboxil?
tivoxavir marboxil is being developed by TRAWS PHARMA, INC..
What is tivoxavir marboxil's latest FDA decision?
The most recent tracked FDA decision for tivoxavir marboxil is FDA_Meeting for The Company received guidance from the FDA regarding its investigational bird flu and seasonal flu product candidate and plans for stockpiling for pandemic preparedness..
Get deeper analysis on tivoxavir marboxil
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis